Bonstetten, Switzerland

Christian Klein

USPTO Granted Patents = 170 

 

Average Co-Inventor Count = 5.6

ph-index = 24

Forward Citations = 1,684(Granted Patents)


Inventors with similar research interests:


Location History:

  • Weilham, DE (1992)
  • Weilheim, DE (1988 - 2018)
  • Iffeldorf, DE (2008 - 2023)
  • Bonstetten, CH (2014 - 2024)
  • Schlieren, CH (2019 - 2024)

Company Filing History:


Years Active: 1988-2025

Loading Chart...
Loading Chart...
170 patents (USPTO):

Title: Christian Klein: Pioneering Innovations in Cancer Treatment

Introduction:

Christian Klein, a renowned inventor and innovator based in Bonstetten, Switzerland, has made significant contributions to the field of medicine through his groundbreaking patents. With an impressive portfolio of 135 patents to his name, Klein has been at the forefront of developing novel therapies for the treatment of cancer. This article will delve into his latest patents, career highlights, notable collaborations, and shed light on his remarkable contributions to the field of medical innovation.

Latest Patents:

Klein's latest patents showcase his innovative approach towards the development of therapies targeting cancer cells. One notable patent is titled "Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine." This patent describes the creation of bispecific monoclonal antibody molecules, which have a first binding domain attaching to an antigen on CD8+ T-cells and a second binding domain targeting a tumor-specific antigen on the surface of tumor cells. These molecules, when combined with transduced CD8+ T-cells, provide a promising method for the treatment of various diseases.

Another groundbreaking patent from Klein is for "Combination therapy of anti-CD20/anti-CD3 bispecific antibodies and 4-1BB (CD137) agonists." This patent focuses on the use of combination therapies employing anti-CD20/anti-CD3 bispecific antibodies alongside 4-1BB (CD137) agonists. Particularly, the patent highlights the therapeutic potential for treating cancer and presents methods for utilizing this combination therapy in clinical applications.

Career Highlights:

Christian Klein has had a distinguished career, marked by numerous accomplishments and contributions to medical innovation. Notably, he has worked with esteemed organizations such as Hoffmann-La Roche Inc., a leading pharmaceutical company, and Roche Glycart AG, a subsidiary specializing in the field of immune-oncology.

Collaborations:

Throughout his career, Klein has collaborated with talented individuals who share his passion for developing groundbreaking medical solutions. Two notable colleagues include Pablo Umana and Ekkehard Moessner. Their combined expertise and dedication have undoubtedly played a crucial role in the successful realization and application of Klein's inventions.

Conclusion:

Christian Klein's impressive portfolio of patents and his relentless pursuit of innovation have established him as a leading figure in the field of medical advancements, specifically in the area of cancer treatment. Through the development of bispecific antibody molecules and combination therapies, Klein's work offers new possibilities for improved patient care and outcomes.

As Klein's contributions continue to shape the landscape of medical innovation, it is clear that his dedication to finding novel solutions for complex medical challenges remains unwavering. His work is a testament to the transformative potential of patents and inventions in advancing the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…